�����

Chemical Engineering—The partnership with New Iridium focuses on CO2 conversion via photocatalysis, the startup’s expertise, which is an innovative solution based on the use of light sources (for example, LEDs) and CO2 from industrial emissions in combination with low-cost raw materials.

What if improving one’s athletic performance through supplements was simpler and more affordable? What if, instead of producing emissions, airplanes could take carbon out of the air? These ideas and more are realities in the making, thanks to many aspiring entrepreneurs who pitched their products at the 16th annual New Venture Challenge (NVC) finals.

Scientists from è������ and the National Institute of Standards and Technology (NIST) made an important leap forward in the quest to diagnose disease using exhaled breath, reporting that a new laser-based breathalyzer—born of Nobel Prize-winning technology from CU—powered by artificial intelligence (AI) can detect COVID-19 in real-time with excellent accuracy.

Endpoints News—OnKure Therapeutics has lined up $60 million in a new private funding round, adding to the è������ spinout’s bank account as it works through a Phase II trial. The startup is attempting to create an inhibitor of histone deacetylases, or HDACs, which are DNA-manipulating enzymes that alter how genes get expressed.

US Department of Energy—OMC Hydrogen, a è������ spinout from Professor Alan W. Weimer's lab, won first place at the US Department of Energy's (DOE) Most Epic Cleantech Pitch Competition. The company is developing green hydrogen technology that eliminates the significant carbon emissions found in other hydrogen production methods.

On two exciting nights of pitches and prizes, ten startups brought a broad range of ideas to the stage, including how to live and garden more sustainably, how to deal with the downsides of social media, how to offer practical prosthetics for kids—and sustainable water filters and hydroponic produce for all. Across the two events, eight teams took home a total of $20,000 to develop their ideas further.

As a first-generation college student turned molecular biologist, Brian DeDecker imagines a day when humble soybeans beans, which his family has grown for generations, pack a bounty of therapeutic but hard-to-obtain natural compounds.

VegWorld Magazine—Meati Foods, a è������ spinout and the producer of delicious animal-free, whole-food protein, this week debuted an evolving chef partnership series coined the “Meati Culinary Collective,” featuring Meati’s mushroom root-based creations as prepared by a diverse roster of celebrated chefs.

GEN—Xalud Therapeutics, a è������ spinout, is developing a non-viral DNA-delivered therapy platform to treat conditions caused by pathologic inflammation 

New research from è������ could ultimately pave the way to novel approaches for treating a host of human diseases, from autoimmune disorders like Rheumatoid arthritis and Crohn’s disease to neurodegenerative diseases like Parkinson’s disease.